Evidence map›Paper›PMID 41428274›Full record

ReviewMagma (New York, N.Y.)2026

In-cell NMR spectroscopy: advancements, applications, challenges, and future directions in structural biology.

Omar Eladl

Abstract readReview
PubMed Publisher
In one paragraph

Review in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Short peptide 803sp inhibits the inflammatory response induced byFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Omar EladlFaculty of Pharmacy, King Salman International University (KSIU), Ras Sudr, South Sinai, Egypt. omarsobhyeladl@gmail.com.ORCID http://orcid.org/0000-0003-0415-6179

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-cell nuclear magnetic resonance (NMR) spectroscopy has emerged as a leading technique in structural biology, providing atomic-level insights into the structures, dynamics, and interactions of biomolecules within their native cellular environments. By bridging the gap between conventional in vitro studies and the complexity of living systems, in-cell NMR enables direct observation of biomolecular behavior under near-physiological conditions. This review highlights recent methodological advances that have expanded the scope and feasibility of in-cell NMR. Innovations in isotopic labeling, including selective incorporation strategies, have enhanced spectral resolution and sensitivity. Optimized delivery approaches, such as microinjection and electroporation, facilitate efficient introduction of labeled biomolecules into diverse cell types. The use of cryogenically cooled probes and high-field magnets further improves signal detection, enabling the study of low-abundance targets. We discuss key applications, including protein folding, conformational dynamics, biomolecular interaction networks, and nucleic acid structural rearrangements. In addition, in-cell NMR has proven invaluable for drug discovery, providing mechanistic insights into intracellular drug-target interactions. Despite these advances, challenges remain, including spectral overlap from endogenous components, low intracellular concentrations, and maintaining cell viability during extended experiments. Future developments integrating cryo-electron microscopy (cryo-EM), mass spectrometry (MS), hyperpolarization techniques, and advanced labeling strategies promise to enhance sensitivity, resolution, and applicability, solidifying in-cell NMR as an indispensable tool for probing biomolecular function in living cells.

Indexed as

Nuclear Magnetic Resonance, BiomolecularAnimalsCryoelectron MicroscopyDrug DiscoveryHumansIsotope LabelingMagnetic Resonance SpectroscopyMass SpectrometryNucleic AcidsProtein ConformationProtein FoldingProteinsNucleic AcidsProteinsBiomolecular interactionCellular structural biologyDrug discoveryIn-cell NMR spectroscopyNuclear magnetic resonance

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.